Insider Trading activities of Eyepoint Pharmaceuticals, Inc. (EYPT)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Eyepoint Pharmaceuticals, Inc. (EYPT) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Eyepoint Pharmaceuticals, Inc. since year 2005. Table 2 shows the detailed insider transactions of Eyepoint Pharmaceuticals, Inc. since 2005. The reporting company's ticker symbol is EYPT. The reporting company's CIK number is 1314102.
The total value of stock buying since 2005 is $31,075,190.
The total value of stock sales since 2005 is $1,268,163.
The total value of stock option exercises since 2005 is $677,697.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Eyepoint Pharmaceuticals, Inc. (EYPT).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2019-06 0 $0 0 $0 159,148 $0
2019-05 40,000 $69,600 0 $0 0 $0
2019-04 5,000 $9,450 0 $0 25,000 $44,450
2019-03 45,500 $80,029 0 $0 20,000 $35,400
2018-12 0 $0 0 $0 62,892 $0
2018-11 0 $0 0 $0 100,000 $112,999
2018-06 16,864,066 $21,333,043 0 $0 111,666 $0
2018-05 0 $0 0 $0 12,500 $0
2018-04 0 $0 0 $0 120,000 $135,600
2018-03 8,606,324 $9,466,956 0 $0 0 $0
2017-06 56,700 $99,962 0 $0 0 $0
2016-03 0 $0 0 $0 10,000 $11,299
2016-01 0 $0 5,000 $23,500 5,000 $9,050
2015-12 0 $0 155,000 $834,053 155,000 $198,949
2015-08 0 $0 5,000 $20,250 5,000 $9,050
2014-10 0 $0 10,000 $42,699 10,000 $11,299
2014-09 0 $0 10,000 $47,800 10,000 $11,299
2014-08 0 $0 10,000 $43,700 10,000 $11,299
2014-07 0 $0 10,000 $43,200 10,000 $11,299
2014-06 0 $0 46,100 $184,891 46,100 $65,415
2014-05 0 $0 7,000 $28,070 7,000 $10,289
2012-10 10,000 $16,150 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Eyepoint Pharmaceuticals, Inc. insiders (EYPT)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2019-06-27 Paggiarino Dario A. (Chief Medical Officer) Option Ex 10,000 .00 0
2019-06-27 Ross Leonard S (See Remarks) Option Ex 6,667 .00 0
2019-06-27 Lurker Nancy (President & CEO) Option Ex 40,000 .00 0
2019-06-21 Duker Jay S. Option Ex 6,667 .00 0
2019-06-21 Peterson Kristine Option Ex 6,667 .00 0
2019-06-21 Godshall Douglas Evan Option Ex 6,667 .00 0
2019-06-21 Mazzo David J Option Ex 8,333 .00 0
2019-06-21 Rogers Michael W Option Ex 6,667 .00 0
2019-06-14 Paggiarino Dario A. (Chief Medical Officer) Option Ex 14,200 .00 0
2019-06-14 Ross Leonard S (See Remarks) Option Ex 8,280 .00 0
2019-06-14 Lurker Nancy (President & CEO) Option Ex 45,000 .00 0
2019-05-13 Landis John B. Buy 40,000 1.74 69,600
2019-04-12 Duker Jay S. Option Ex 20,000 1.77 35,400
2019-04-01 Duker Jay S. Buy 5,000 1.89 9,450
2019-04-01 Ross Leonard S (See Remarks) Option Ex 5,000 1.81 9,050
2019-03-29 Lurker Nancy (President & CEO) Buy 28,500 1.76 50,245
2019-03-29 Godshall Douglas Evan Buy 17,000 1.75 29,784
2019-03-29 Mazzo David J Option Ex 20,000 1.77 35,400
2018-12-22 Ross Leonard S (See Remarks) Option Ex 62,892 .00 0
2018-11-15 Rogers Michael W (Director) Option Ex 100,000 1.13 112,999
2018-06-27 Duker Jay S. (Director) Option Ex 12,500 .00 0
2018-06-27 Paggiarino Dario A. (Chief Medical Officer) Option Ex 10,000 .00 0
2018-06-27 Ross Leonard S (See Remarks) Option Ex 6,666 .00 0
2018-06-27 Lurker Nancy (President & CEO) Option Ex 40,000 .00 0
2018-06-27 Godshall Douglas Evan (Director) Option Ex 12,500 .00 0
2018-06-27 Mazzo David J (Director) Option Ex 17,500 .00 0
2018-06-27 Rogers Michael W (Director) Option Ex 12,500 .00 0
2018-06-25 Essex Woodlands Ix, Llc (10% Owner) Buy 16,864,066 1.26 21,333,043
2018-05-07 Barry James J (Director) Option Ex 12,500 .00 0
2018-04-20 Mazzo David J (Director) Option Ex 120,000 1.13 135,600
2018-03-28 Essex Woodlands Ix, Llc (10% Owner) Buy 8,606,324 1.10 9,466,956
2017-06-14 Lurker Nancy (President and CEO) Buy 56,700 1.76 99,962
2016-03-18 Ashton Paul (President & CEO) Option Ex 10,000 1.13 11,299
2016-01-04 Ross Leonard S (Vice President, Finance) Sale 5,000 4.70 23,500
2016-01-04 Ross Leonard S (Vice President, Finance) Option Ex 5,000 1.81 9,050
2015-12-22 Ross Leonard S (Vice President, Finance) Sale 33,950 5.39 182,990
2015-12-22 Ross Leonard S (Vice President, Finance) Option Ex 33,950 1.81 61,449
2015-12-22 Ashton Paul (President & CEO) Sale 120,000 5.39 646,800
2015-12-22 Ashton Paul (President & CEO) Option Ex 120,000 1.13 135,600
2015-12-01 Ross Leonard S (Vice President, Finance) Sale 1,050 4.06 4,263
2015-12-01 Ross Leonard S (Vice President, Finance) Option Ex 1,050 1.81 1,900
2015-08-03 Ross Leonard S (Vice President, Finance) Sale 5,000 4.05 20,250
2015-08-03 Ross Leonard S (Vice President, Finance) Option Ex 5,000 1.81 9,050
2014-10-01 Ashton Paul (President & CEO) Sale 10,000 4.27 42,699
2014-10-01 Ashton Paul (President & CEO) Option Ex 10,000 1.13 11,299
2014-09-02 Ashton Paul (President & CEO) Sale 10,000 4.78 47,800
2014-09-02 Ashton Paul (President & CEO) Option Ex 10,000 1.13 11,299
2014-08-01 Ashton Paul (President & CEO) Sale 10,000 4.37 43,700
2014-08-01 Ashton Paul (President & CEO) Option Ex 10,000 1.13 11,299
2014-07-01 Ashton Paul (President & CEO) Sale 10,000 4.32 43,200
2014-07-01 Ashton Paul (President & CEO) Option Ex 10,000 1.13 11,299
2014-06-19 Ashton Paul (President & CEO) Sale 3,069 4.00 12,276
2014-06-19 Ashton Paul (President & CEO) Option Ex 3,069 1.13 3,467
2014-06-18 Ashton Paul (President & CEO) Sale 3,931 4.00 15,724
2014-06-18 Ashton Paul (President & CEO) Option Ex 3,931 1.13 4,442
2014-06-17 Freedman Lori (VP Corp. Affairs, GC and Sec) Sale 4,464 4.00 17,856
2014-06-17 Freedman Lori (VP Corp. Affairs, GC and Sec) Option Ex 4,464 1.81 8,079
2014-06-17 Ashton Paul (President & CEO) Sale 4,500 4.00 18,000
2014-06-17 Ashton Paul (President & CEO) Option Ex 4,500 1.13 5,084
2014-06-16 Freedman Lori (VP Corp. Affairs, GC and Sec) Sale 3,436 4.01 13,778
2014-06-16 Freedman Lori (VP Corp. Affairs, GC and Sec) Option Ex 3,436 1.81 6,219
2014-06-16 Ashton Paul (President & CEO) Sale 3,200 4.01 12,832
2014-06-16 Ashton Paul (President & CEO) Option Ex 3,200 1.13 3,615
2014-06-13 Freedman Lori (VP Corp. Affairs, GC and Sec) Sale 2,100 4.01 8,421
2014-06-13 Freedman Lori (VP Corp. Affairs, GC and Sec) Option Ex 2,100 1.81 3,801
2014-06-13 Ashton Paul (President & CEO) Sale 2,200 4.01 8,822
2014-06-13 Ashton Paul (President & CEO) Option Ex 2,200 1.13 2,485
2014-06-12 Freedman Lori (VP Corp. Affairs, GC and Sec) Sale 9,600 4.02 38,591
2014-06-12 Freedman Lori (VP Corp. Affairs, GC and Sec) Option Ex 9,600 1.81 17,376
2014-06-12 Ashton Paul (President & CEO) Sale 9,600 4.02 38,591
2014-06-12 Ashton Paul (President & CEO) Option Ex 9,600 1.13 10,847
2014-05-05 Freedman Lori (VP Corp. Affairs, GC and Sec) Sale 3,500 4.01 14,035
2014-05-05 Freedman Lori (VP Corp. Affairs, GC and Sec) Option Ex 3,500 1.81 6,335
2014-05-05 Ashton Paul (President & CEO) Sale 3,500 4.01 14,035
2014-05-05 Ashton Paul (President & CEO) Option Ex 3,500 1.13 3,954
2012-10-01 Hopper Paul (Director) Buy 10,000 1.61 16,150

Insider trading activities including stock purchases, stock sales, and option exercises of EYPT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Eyepoint Pharmaceuticals, Inc. (symbol EYPT, CIK number 1314102) see the Securities and Exchange Commission (SEC) website.